Blue Goat Cyber

Blue Goat Cyber Blue Goat Cyber is a leading consultancy specializing in medical device cybersecurity.

We provide expert medical device cybersecurity services, specializing in FDA premarket submissions, postmarket management, risk management, threat modeling, secure development, and regulatory compliance, focused on patient safety and compliance. Founded by Christian Espinosa, a recognized expert in the field, our company provides comprehensive cybersecurity solutions tailored to the unique needs o

f medical device manufacturers. With a deep understanding of both regulatory requirements and the evolving threat landscape, Blue Goat Cyber is your trusted partner in navigating the complexities of FDA premarket submissions and postmarket management. At Blue Goat Cyber, we excel at simplifying complex cybersecurity challenges, ensuring that your devices not only meet stringent regulatory standards but also operate securely throughout their lifecycle. Our team combines extensive industry experience with cutting-edge cybersecurity practices to deliver customized strategies that mitigate risks and enhance device security. Whether you’re preparing for an FDA submission, conducting threat modeling, or managing postmarket surveillance, Blue Goat Cyber offers the expertise and support you need to protect your devices and patients. Our mission is to empower medical device manufacturers with the knowledge and tools to achieve robust cybersecurity, ensuring patient safety and regulatory compliance at every stage.

Failure Mode and Effects Analysis (FMEA) and threat modeling both evaluate risk, but they answer very different question...
08/30/2026

Failure Mode and Effects Analysis (FMEA) and threat modeling both evaluate risk, but they answer very different questions.

FMEA focuses on how a product might fail due to accidental causes, while threat modeling examines how an attacker could intentionally exploit vulnerabilities. Relying on one without the other can leave important risks unaddressed, especially as connected medical devices become more complex.

Understanding where each methodology fits helps manufacturers build a more complete risk management strategy while meeting today's cybersecurity expectations.

See why these two approaches address different risks and why both belong in your cybersecurity strategy: https://bluegoatcyber.com/blog/fmea-vs-threat-modeling-medical-devices

As medical devices become more connected, the potential consequences of a cyberattack extend well beyond IT systems. A s...
08/29/2026

As medical devices become more connected, the potential consequences of a cyberattack extend well beyond IT systems. A successful attack can disrupt therapy, alter clinical data, or take critical devices offline, affecting patient safety and hospital operations. For manufacturers, the impact may also include regulatory action, product recalls, legal liability, and lasting damage to customer trust.

Key takeaway: Medical device cybersecurity is fundamentally about protecting patient safety. A strong security program helps reduce operational risk while supporting regulatory compliance and long-term confidence in your products.

Learn how proactive threat modeling and pe*******on testing can help identify vulnerabilities before they become real-world risks: https://bluegoatcyber.com/ask-the-goat

08/28/2026

MedTech companies can have exciting technology, strong teams and ambitious fundraising goals, but investors will quickly notice when the claims do not line up with the evidence.

In this episode of the Med Device Cyber Podcast, Ryan Roghaar shares that five out of seven companies in one recent cohort were making claims they could not adequately back up, including businesses pursuing raises of around $25 million. That kind of inconsistency can create doubt before a founder ever gets the opportunity to fully explain the business.

For an investor reviewing multiple opportunities every day, a questionable claim does not always lead to a deeper investigation. Sometimes it simply gives them a reason to move on to the next company.

The takeaway is simple: strong messaging has to be supported by strong evidence. Your pitch may get attention, but credibility is what keeps the conversation moving.

Hear more from Ryan Roghaar, founder of RŌG Health, and Christian Espinosa on the latest episode of the Med Device Cyber Podcast: https://mdcpodcast.com/episodes/the-3-commercialization-mistakes-killing-medtech-startups-with-ryan-roghaar-ep-8-olGgDd2l1RQ

Not every medical device falls under FDA Section 524B, but determining whether a legacy device is subject to today's cyb...
08/28/2026

Not every medical device falls under FDA Section 524B, but determining whether a legacy device is subject to today's cybersecurity requirements isn't always straightforward.

As manufacturers continue supporting products already on the market, questions often arise around software updates, design changes, new submissions, and ongoing regulatory obligations. Understanding where legacy devices fit into the evolving regulatory landscape is becoming increasingly important for product teams managing long device lifecycles.

Knowing when Section 524B applies can help organizations make more informed decisions about planning, maintenance, and future submissions.

Get clarity on how Section 524B may affect your existing product portfolio: https://bluegoatcyber.com/blog/does-fda-section-524b-apply-to-legacy-medical-devices

One more day. One more chance to talk medical device cybersecurity.If you’re navigating cybersecurity requirements, prep...
08/27/2026

One more day. One more chance to talk medical device cybersecurity.

If you’re navigating cybersecurity requirements, preparing a device for submission, planning pe*******on testing, or trying to identify gaps before they become regulatory roadblocks, stop by the Blue Goat Cyber booth.

Our team is here to answer questions and talk through the cybersecurity challenges affecting your device and regulatory strategy.

Before you leave MedTech World Asia, come say hello and meet the Goats.

How deal ready is your MedTech company when due diligence begins?Investors and acquirers are looking beyond growth poten...
08/26/2026

How deal ready is your MedTech company when due diligence begins?

Investors and acquirers are looking beyond growth potential. Regulatory strategy, quality, cybersecurity, and other operational risks can influence whether a transaction moves forward or encounters unexpected roadblocks.

During a sponsored luncheon at MedTech World Asia, Christian Espinosa, Joseph Ho of the University of Hong Kong, Edwin Lindsay of CS Life Sciences, and Chris Japp of Tramway Ventures will examine the gaps that can emerge between initial interest and a completed deal.

Join the conversation, From Due Diligence to Deal Ready: What Investors and Acquirers See Before They Say Yes, from 13:10–14:10 HKT.

08/26/2026

Ernest Shackleton learned an interesting lesson about recruiting before LinkedIn ever existed.

When he made his Antarctic expedition sound glamorous, he attracted the wrong candidates. When the posting described what they would actually face, bitter cold, small wages, months of darkness, constant danger, and no guarantee of returning safely, the right people wanted in.

There’s something MedTech companies can take from that.

Trying to make every opportunity attractive to everyone can work against you. Be clear about the culture, expectations, challenges, and reality of the role so the right people can decide they want to be part of it.

Catch Christian Espinosa and Darwin Shurig, founder of Top Talent Accelerant, on the Med Device Cyber Podcast for more on finding talent that actually fits: https://mdcpodcast.com/episodes/25-of-job-candidates-are-fake-medtech-hiring-in-the-age-of-ai-with-darwin-shurig-EMWUOE-S2LY

Breaking into Europe and the U.S. takes more than regulatory approval.Successful market expansion requires a strategy th...
08/25/2026

Breaking into Europe and the U.S. takes more than regulatory approval.

Successful market expansion requires a strategy that balances regulatory requirements with commercial realities. From reimbursement and pricing to quality systems, documentation, and cybersecurity, every decision can influence how quickly and effectively a medical device reaches new markets.

Industry experts come together at MedTech World Asia to discuss the critical considerations for expanding beyond APAC and why building cybersecurity into your product strategy from the beginning can help support long-term success in Europe and the United States.

Join us at 10:40 AM HKT for "Beyond APAC: Building a MedTech Expansion Strategy for Europe and the USA." We look forward to seeing you there.

08/24/2026

What happens when AI starts hiring AI?

Companies are using AI to screen growing numbers of applications. Candidates are using AI to tailor resumes and improve their chances of getting through those same systems.

The result? Strong candidates can get screened out, while others land interviews because their resume was optimized for the process, even when they cannot speak confidently about what is on it.

At its most extreme, Darwin Shurig says there are already scenarios where AI systems are essentially interviewing each other.

Where does human judgment fit when both sides are optimizing for an algorithm?

Join Christian Espinosa and Darwin Shurig for the conversation on the Med Device Cyber Podcast: https://mdcpodcast.com/episodes/25-of-job-candidates-are-fake-medtech-hiring-in-the-age-of-ai-with-darwin-shurig-EMWUOE-S2LY

Cybersecurity failures don't always begin with a sophisticated attack. Sometimes, they start with decisions made long be...
08/23/2026

Cybersecurity failures don't always begin with a sophisticated attack. Sometimes, they start with decisions made long before a device reaches the market.

Waiting to address cybersecurity until late in development can lead to delayed submissions, costly redesigns, increased regulatory scrutiny, and damaged customer confidence. The impact extends beyond compliance. It can affect product timelines, business objectives, and ultimately patient trust.

Building cybersecurity into the development process from the beginning helps reduce risk while creating a stronger foundation for long-term success.

Learn what's really at stake when cybersecurity is treated as a late-stage activity: https://bluegoatcyber.com/blog/fda-cybersecurity-failure-consequences-medical-devices

Address

1776 North Scottsdale Road, Unit 727
Scottsdale, AZ
82527

Telephone

+13073178884

Website

Alerts

Be the first to know and let us send you an email when Blue Goat Cyber posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Blue Goat Cyber:

Shortcuts

Share

Category